Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Insmed (INSM) Operating Expenses (2016 - 2026)

Insmed's Operating Expenses history spans 17 years, with the latest figure at $459.3 million for Q1 2026.

  • Quarterly Operating Expenses rose 34.7% to $459.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.0 billion through Mar 2026, up 44.76% year-over-year, with the annual reading at $1.9 billion for FY2025, 49.22% up from the prior year.
  • Operating Expenses came in at $459.3 million for Q1 2026, down from $583.6 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $583.6 million in Q4 2025 to a low of $142.9 million in Q1 2022.
  • The 5-year median for Operating Expenses is $306.9 million (2024), against an average of $310.1 million.
  • Year-over-year, Operating Expenses soared 103.7% in 2023 and then rose 3.58% in 2024.
  • Insmed's Operating Expenses stood at $210.8 million in 2022, then grew by 24.29% to $262.0 million in 2023, then grew by 27.82% to $334.9 million in 2024, then soared by 74.28% to $583.6 million in 2025, then dropped by 21.3% to $459.3 million in 2026.
  • Per Business Quant, the three most recent readings for INSM's Operating Expenses are $459.3 million (Q1 2026), $583.6 million (Q4 2025), and $508.3 million (Q3 2025).